Molecular map of liver disease could transform how disease is diagnosed and monitored

Molecular map of liver disease could transform how disease is diagnosed and monitored. A study led by researchers at Open Targets, EMBL's European Bioinformatics Institute (EMBL-EBI), the University of Cambridge and others has identified a set of plasma proteins that could be used to diagnose and monitor patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: A study led by researchers at Open Targets, EMBL's European Bioinformatics Institute (EMBL-EBI), the University of Cambridge and others has identified a set of plasma proteins that could be used to diagnose and monitor patients with metabolic dysfunction-associated steatotic liver disease (MASLD). It was published today in Nature Metabolism.

• Ponto de atenção: molecular.
• Ponto de atenção: liver.
• Ponto de atenção: disease.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.